Most Read Articles
Audrey Abella, 31 Jan 2017
Nonsteroidal anti-inflammatory drug (NSAID) treatment for patent ductus arteriosus (PDA) in preterm infants did not reduce the odds of mortality or bronchopulmonary dysplasia (BPD), a recent US study found.
Jairia Dela Cruz, 13 Oct 2016
Children born to obese mothers are at increased risk of developing autism spectrum disorder (ASD) compared with children born to normal-weight mothers, according to data from a review and meta-analysis.
Yap Te-Lu, Anette Sundfor Jacobsen, 01 Oct 2013

Antenatal hydronephrosis (ANH) is a general term used to describe the dilatation of the fetal renal pelvis and/or its calyces. In pelviectasis, there is only dilatation of the renal pelvis; while in caliectasis, there is dilatation of the calyces. ANH is the most commonly diagnosed congenital urinary tract anomaly, which is detected by prenatal screening in 1–5% of all pregnancies

Golimumab shows potential in treatment of paediatric polyJIA patients

21 Aug 2017

Golimumab appears to induce rapid, clinically meaningful improvements in children with active polyarticular-course juvenile idiopathic arthritis (polyJIA), according to the results of a trial that did not meet its primary endpoint.

The three-part randomized withdrawal trial included 173 paediatric polyJIA patients treated with open-label golimumab (30 mg/m2 of body surface area; maximum, 50 mg/dose) every 4 weeks in combination with weekly methotrexate during part 1 (weeks 0 to 16). Patients showing at least 30 percent improvement in the American College of Rheumatology Criteria for JIA (JIA ACR30) in part 1 entered the double-blinded part 2 (weeks 16 to 48) and were randomized to either continue golimumab or start placebo. In part 3, golimumab was continued or could be restarted as in part 1.

The primary outcome was JIA flares in part 2, whereas secondary outcomes included JIA ACR50/70/90 responses, clinical remission, PK and safety.

Of the patients, 89.0 percent showed a JIA ACR30 response in part 1. The corresponding percentage of patients who demonstrated JIA ACR50/70/90 responses were 79.2, 65.9 and 36.4 percent.

At week 48, the primary endpoint was not met as JIA flare rates were comparable between the two treatment groups (41 percent with golimumab vs 47 percent with placebo; p=0.41). Likewise, rates of clinical remission were similar (12.8 vs 11.8 percent).

In terms of safety, adverse event and serious adverse event rates did not significantly differ between the treatment groups during part 2. Injection site reactions occurred with <1 percent of all injections. Adequate golimumab dosing for polyJIA was confirmed in pharmacokinetic analysis.

First-line drugs used in the treatment of children with polyJIA include nonsteroidal anti-inflammatory drugs and methotrexate. Those who are intolerant to MTX or fail to achieve adequate disease control may require treatment with biological disease-modifying antirheumatic drugs (DMARDs) such as golimumab, a fully human, antitumour necrosis factor (TNF)α monoclonal antibody that can be administered by either intravenous infusion or subcutaneous injection. [J Rheumatol 2004;31:390–2; Arthritis Care Res 2011;63:465–82; Nat Rev Rheumatol 2015;11:290–300]

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Audrey Abella, 31 Jan 2017
Nonsteroidal anti-inflammatory drug (NSAID) treatment for patent ductus arteriosus (PDA) in preterm infants did not reduce the odds of mortality or bronchopulmonary dysplasia (BPD), a recent US study found.
Jairia Dela Cruz, 13 Oct 2016
Children born to obese mothers are at increased risk of developing autism spectrum disorder (ASD) compared with children born to normal-weight mothers, according to data from a review and meta-analysis.
Yap Te-Lu, Anette Sundfor Jacobsen, 01 Oct 2013

Antenatal hydronephrosis (ANH) is a general term used to describe the dilatation of the fetal renal pelvis and/or its calyces. In pelviectasis, there is only dilatation of the renal pelvis; while in caliectasis, there is dilatation of the calyces. ANH is the most commonly diagnosed congenital urinary tract anomaly, which is detected by prenatal screening in 1–5% of all pregnancies